These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [A new drug for macular degeneration. A breakthrough accomplished (interview by Waldtraud Paukstadt)]. Holz FG MMW Fortschr Med; 2007 Jan; 149(3):13-4. PubMed ID: 17619376 [No Abstract] [Full Text] [Related]
3. AMD: out of sight out of mind. Pountney D Nurs Older People; 2007 Dec; 19(10):16-9. PubMed ID: 18220063 [No Abstract] [Full Text] [Related]
4. Bevacizumab and ranibizumab. Bevacizumab and the inverse postcode lottery. Harris MJ BMJ; 2010 Jul; 341():c3718. PubMed ID: 20627986 [No Abstract] [Full Text] [Related]
5. Saving money on the PBS: ranibizumab or bevacizumab for neovascular macular degeneration? Harvey KJ; Day RO; Campbell WG; Lipworth W Med J Aust; 2011 Jun; 194(11):567-8. PubMed ID: 21644867 [TBL] [Abstract][Full Text] [Related]
9. Ranibizumab vs. pegaptanib: a cost-effectiveness study? Wiwanitkit V Graefes Arch Clin Exp Ophthalmol; 2010 Nov; 248(11):1675; author reply 1677. PubMed ID: 20424851 [No Abstract] [Full Text] [Related]
10. [Treatment of neovascular age-related macular degeneration with bevacizumab]. Monzón Moreno A Farm Hosp; 2006; 30(6):387-8. PubMed ID: 17298199 [No Abstract] [Full Text] [Related]
11. A cost-effectiveness analysis of three treatments for age-related macular degeneration. Gower EW; Cassard SD; Bass EB; Schein OD; Bressler NM Retina; 2010 Feb; 30(2):212-21. PubMed ID: 19940805 [TBL] [Abstract][Full Text] [Related]
12. [The current state and issues of medical treatment for age-related macular degeneration]. Ishida S Nihon Yakurigaku Zasshi; 2008 Jan; 131(1):47-9. PubMed ID: 18187884 [No Abstract] [Full Text] [Related]
13. [VEGF inhibitors in ophthalmology]. Thys J; Dupont G; Rakic JM Rev Med Liege; 2009; 64(5-6):323-6. PubMed ID: 19642468 [TBL] [Abstract][Full Text] [Related]